✓Aug 10 session - Last update: Aug 10, 2026, 5:39 PM ET
🏆Material / Earnings✓High confidence
Source: earnings_events
Changes History →Pre-market · Regular session opens 9:30 AM ET
Last update: Aug 10, 2026, 6:28 PM ETMarket closed·115 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Aug 10 session - Last update: Aug 10, 2026, 5:38 PM ET
⚠️Material / Earnings✓High confidence
What changed: AST SpaceMobile, Inc. (ASTS) reported EPS of -$0.44 vs. -$0.32 consensus estimate for Q2 FY2026 on August 10, 2026, missing consensus by 37.5%.
Source: earnings_events
Changes History →What's next
What to watch
Monitor the next quarterly earnings report and any updates on cash position or burn rate guidance.
✓Aug 10 session - Last update: Aug 10, 2026, 5:30 PM ET
⚠️Material / Earnings✓High confidence
What changed: Aecom (ACM) reported EPS of −$0.50 vs. consensus estimate of $1.46 for Q3 FY2026, missing by 134.2%.
Source: earnings_events
Changes History →What's next
What to watch
Management's guidance for full-year FY2026 results and any commentary on cost pressures or project delays during the earnings call.
✓Aug 10 session - Last update: Aug 10, 2026, 5:29 PM ET
⚠️Material / Earnings✓High confidence
What changed: BridgeBio Pharma, Inc. (BBIO) reported EPS of −$0.78 vs. −$0.58 estimate for Q2 FY2026, missing consensus by 35.5%.
Source: earnings_events
Changes History →What's next
What to watch
BBIO earnings scheduled for 2026-11-04 (consensus EPS estimate −$0.49).
✓Aug 10 session - Last update: Aug 10, 2026, 5:17 PM ET
🏆Material / Earnings✓High confidence
What changed: Rocket Lab USA, Inc. (RKLB) reported EPS of −$0.03 vs. −$0.06 estimate for Q2 FY2026, beating consensus by 48.6%.
Source: earnings_events
Changes History →What's next
What to watch
RKLB is scheduled to report Q3 FY2026 earnings on 2026-11-09 (date not yet confirmed), with consensus EPS estimate of −$0.03.
✓Aug 10 session - Last update: Aug 10, 2026, 5:15 PM ET
🏆Material / Earnings✓High confidence
What changed: AAON, Inc. (AAON) reported EPS of $0.69 vs. consensus estimate of $0.51 for Q2 FY2026, beating consensus by 34.5%.
Source: earnings_events
Changes History →What's next
What to watch
AAON earnings scheduled for November 5, 2026, with consensus EPS estimate of $0.67.
✓Aug 10 session - Last update: Aug 10, 2026, 5:14 PM ET
⚠️Material / Earnings✓High confidence
What changed: Hims & Hers Health, Inc. (HIMS) reported EPS of –$0.10 vs. –$0.05 estimate on 2026-08-10, missing consensus by 100.8%.
Source: earnings_events
Changes History →What's next
What to watch
HIMS earnings scheduled for 2026-11-02 with consensus EPS estimate of $0.12.
✓Aug 10 session - Last update: Aug 10, 2026, 4:52 PM ET
⚡Material / Earnings✓High confidence
What changed: Figma, Inc. (FIG) moved +10.87% from $22.90 to $25.39 on 2026-08-10. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on below-average volume (0.7x the 5-day average), two trading days before FIG's earnings announcement scheduled for 2026-08-14.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
FIG earnings report on 2026-08-14 will reveal actual results versus the $0.04 consensus estimate.
✓Aug 10 session - Last update: Aug 10, 2026, 4:41 PM ET
🛡Material / Earnings✓High confidence
What changed: Lumentum Holdings Inc. (LITE) moved -12.62% from $931.05 to $813.51 on 2026-08-10. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The decline occurred one day before the company's scheduled earnings report on 2026-08-11, with volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Lumentum's earnings report on 2026-08-11, with consensus EPS estimate of $2.97.
✓Aug 10 session - Last update: Aug 10, 2026, 5:38 PM ET
⚠️Material / Earnings✓High confidence
What changed: Axsome Therapeutics, Inc. (AXSM) reported Q2 FY2026 EPS of −$0.99 vs. −$0.89 consensus estimate, missing by 11.0% on 2026-08-10.
Source: earnings_events
Changes History →What's next
What to watch
Monitor AXSM's next earnings release or updated guidance for evidence of margin improvement or revenue acceleration.
✓Aug 10 session - Last update: Aug 10, 2026, 4:56 PM ET
🛡Material / Earnings✓High confidence
What changed: Fervo Energy Co. (FRVO) moved -7.43% from $25.84 to $23.92 on 2026-08-10. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
FRVO earnings report on 2026-09-28 (date to be confirmed).
✓Aug 10 session - Last update: Aug 10, 2026, 4:53 PM ET
🛡Material / Earnings✓High confidence
What changed: Everus Construction Group, Inc. (ECG) moved -5.16% from $139.07 to $131.89 on 2026-08-10. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting typical trading conditions.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
ECG earnings announcement on 2026-08-11 (consensus EPS $1.10) may clarify the sell-off.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
Stock AnalysisAugust 10, 2026 · 13 min read
Why did Vertex Pharmaceuticals (VRTX) stock jump to an all-time high on August 10, 2026?
VRTX traded up 7.00% at $530.78 by 10:46 a.m. ET, touching a fresh all-time high of $546.17. Named analyst price-target actions are dated August 4-5, three to four sessions earlier — but at 7:00 a.m. ET the same morning, competitor Sionna Therapeutics disclosed that its SION-719 cystic-fibrosis trial, dosed alongside Vertex's own therapy, missed its endpoint and would not advance. Sionna's program had been flagged as a real threat to Vertex's CF franchise days earlier; no source found here states the causal link outright, but the timing is hard to read as coincidence.
VRTXRead →
Stock AnalysisAugust 7, 2026 · 15 min read
Why did Axon (AXON) stock rebound on August 7, 2026? A 14% post-earnings drop the sell side kept raising targets into
AXON traded up 7.66% at $562.50 by 1:53 p.m. ET, recovering 46% of Thursday's $87.03 decline. The striking detail is what the sell side did while the stock fell 14.28%: Barclays, Goldman Sachs, Piper Sandler, Morgan Stanley and UBS all raised targets on August 6, and nobody downgraded. Revenue grew 35.3% and guidance went up. Earnings per share fell 13.8% — but mostly against a prior-year tax benefit, which leaves the guided margin trough, still ahead, as the durable concern.
AXONRead →
Stock AnalysisAugust 7, 2026 · 20 min read
Why did SpaceX (SPCX) stock jump on August 7, 2026? An upgrade, a chip fab, and a lock-up that held
SPCX traded up 11.65% at $128.31 by 11:47 a.m. ET after Argus upgraded it to Buy, SpaceX and Tesla confirmed a $16.8 billion chip plant, and 911.5 million insider shares became eligible to trade without breaking the price. None of it changed the $18.369 billion of quarterly capex behind the selloff — and the next unlock tranche is August 20, not December.
SPCXRead →
Stock AnalysisAugust 4, 2026 · 14 min read
Why did Palantir (PLTR) stock jump on August 4, 2026? A 149% U.S. commercial quarter — and the multiple that came with it
Palantir traded up 27.07% at $159.66 by 11:29 a.m. ET after second-quarter revenue grew 93% to $1.935 billion and U.S. commercial revenue grew 149%. Two disclosed lines ran far below that headline: international commercial revenue rose 2% sequentially, and closed contract value grew 49%.
PLTRRead →
Stock AnalysisAugust 3, 2026 · 12 min read
Why did CoreWeave (CRWV) stock jump on August 3, 2026? A neocloud rally, and a loan that priced wider
CoreWeave closed up 19.23% at $85.57 in a market-wide risk-on session, outpacing the Nasdaq-100 proxy by 17.5 points. In the same week its $2.6 billion term loan cleared 100–125 basis points wider than marketed, at a three-point discount to par.
CRWVRead →
Stock AnalysisAugust 2, 2026 · 11 min read
Why Fermi (FRMI) Stock Fell 15% on July 31, 2026 — a De-Rating With No Headline
Fermi closed July 31 down 15.45% at $5.69, erasing the previous session's 14.85% gain — with no company announcement identified. The conditions around it were structural: sell-side targets cut roughly 60% in five weeks, 12.1 million new shares listed in London two days earlier, and a short base up a quarter in a month against a float of 288 million shares.
FRMIRead →